The Motley Fool, founded in 1993 by brothers David and Tom Gardner, is a multimedia financial services company dedicated to empowering individual investors with accessible, actionable advice. Headquartered in Alexandria, Virginia, the company offers a range of products, including stock recommendations, investment research, and personal finance guidance, through its popular website, newsletters, podcasts, and premium subscription services.
Trinity Street Sells $22 Million of Axalta Coating Systems Stock Axalta Coating Systems serves global automotive and industrial markets with specialty coatings and a diverse product lineup.
Down 10% Already in 2026, Is Lululemon Stock a Buy? Despite recently announcing that it expects its fourth-quarter results to be at the high end of its guidance range, shares are getting crushed.
Where Will Rigetti Computing (RGTI) Stock Be in 1 Year? The quantum computing underdog faces tough near-term challenges.
Why Billionaires Are Quietly Buying This AI Stock for 2026 Several billionaires on Wall Street are pouring into one particular member of the "Magnificent Seven."
Could BigBear.ai Stock Go to $0? Not every AI stock is a runaway success story.
Why Micron Stock Popped Again Today If Micron can hit the targets Wall Street is setting for it, the stock looks like a buy.
Why Zscaler Stock Is Up Today The cyber guardian is strengthening its AI defenses.
The Best Index Funds to Buy: Low Cost IVV or Higher Yield DIA? Weighing cost, diversification, and sector focus, IVV and DIA take distinct approaches to building a core U.S. equity portfolio.
2 Biotech Stocks Set to Rebound in 2026 They could perhaps see sustained runs beyond this year.
Where Will Realty Income Stock Be in 1 Year? Realty Income just opened up another avenue for growth.
Why 1 Fund Is Loading Up on RH Stock RH operates a multi-channel platform delivering premium home furnishings to affluent consumers in the U.S., Canada, and the U.K.
Move Over, Tesla Solar. These 2 Energy Stocks Are Powering The Future of AI Virtual Power Plant providers National Grid and Sunrun are providing solutions to keep up with AI power requirements.
1 Pharmaceutical Stock Set to Rebound in 2026 Novo Nordisk stock will ride a wave of demand for Ozempic pills in 2026.
Why Roper Stock Is Plummeting Today Roper's stock continues to sell off as the software specialist's guidance underwhelmed the market.
Why USA Rare Earth Stock Gave Back Its Gains Today USA Rare Earth investors face as much as 75% share dilution -- and they're not all happy about it.
Why The Trade Desk Fell Yet Again Today Multiple Wall Street firms downgraded the stock following yesterday's surprise exit of the company's new CFO.
TikTok Stays in America: The $500 Billion Stock Behind the Deal Investors Need to Know TikTok has finally reached a deal to form a new U.S. entity, officially keeping the platform up and running.
Starbucks Stock Has Soared in 2026. Is It Too Late to Buy? Starbucks is showing early progress, but is the valuation already pricing in too much optimism?
Graphene Investments Liquidates Entire $2.95 Million Bath & Body Works Stake Amid Turnaround Challenges Bath & Body Works delivers personal care and home fragrance products through a broad retail and e-commerce footprint across North America.
Harmony Biosciences' Sales and Profits Have Soared. Why Hasn't Its Stock Followed? Some investors haven't gotten answers to their questions about the biotech stock's past and future.
3 Reasons to Buy Amazon Stock Right Now When the market is pessimistic, that could spell opportunity.
Why CoreWeave Stock is Soaring (Again) Today The neocloud operator got some love from Wall Street.
Why UnitedHealth Group Stock Just Crashed How bad were today's earnings for UnitedHealth Group stock?
This Wealth Manager Just Dumped Its Entire $3.5 Million Stake in the iShares Biotech ETF The iShares Biotechnology ETF tracks U.S. biotech firms, offering exposure to companies advancing research, development, and innovation.
Is Sweetgreen (SG) Yesterday's News? The stock has cratered by more than 75% over the past year, making its stock a bargain -- or a value trap.
Up 36%, Is Eli Lilly Still a Buy? Thanks to its weight loss and diabetes products, the drug company has seen its shares soar.
I predicted a 10% Market Correction in 2025. Here's Why Another Is on the Way in 2026. The S&P 500 fell nearly 20% last April, largely over worries about President Donald Trump's surprising tariff announcements.
1 Investing Rule I Never Break Here's what two of our analysts have learned from their own investing experience.
Why RTX Stock Popped Today RTX is growing sales, earnings, and free cash flow. What could possibly be wrong with that?
3 Myths About Roth Retirement Plans You Shouldn't Believe It's important that you understand how to use these plans efficiently.
2 Pharmaceutical Stocks Set to Rebound in 2026 There might be massive upside ahead for these drugmakers.
Are Telehealth Stocks Set to Tumble in 2026? The challenges keep rolling in for telehealth specialists.
Is It Too Late to Buy Rigetti After Its Massive Run? Rigetti's future could hinge on one breakthrough, and investors who understand the risks today may be best positioned for tomorrow.
Here's Why Feb. 5 Could Be a Big Day for Amazon Investors Amazon's growing portfolio of artificial intelligence initiatives will be in the spotlight in early February.
